- Description
- 1 online resource (16 pages).
- Series Statement
- Report / 116th Congress, 2d session, House of Representatives ; 116-513
- United States. Congress. House. Report ; 116-513.
- Subject
- Genre/Form
- Legislative materials.
- Note
- Bibliography (note)
- Includes bibliographical references.
- Call Number
- GPO Internet Y 1.1/8:116-513
- OCLC
- marcive1227101459
- Author
United States. Congress. House. Committee on Energy and Commerce, author.
- Title
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 : report (to accompany H.R. 4866).
- Publisher
[Washington, D.C.] : [U.S. Government Publishing Office], [2020]
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- Series
Report / 116th Congress, 2d session, House of Representatives ; 116-513
United States. Congress. House. Report ; 116-513.
- Bibliography
Includes bibliographical references.
- Source of description
PDF version; title from caption (govinfo, viewed Dec. 17, 2020).
- Connect to:
- Other Form:
Print version: United States. Congress. House. Committee on Energy and Commerce. National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 (OCoLC)1227101419
Microfiche version: United States. Congress. House. Committee on Energy and Commerce. National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 (OCoLC)1302202545
- Gpo Item No.
1008-I (online)
- Sudoc No.
Y 1.1/8:116-513